Growth Of Gleevec-Resistant Gastrointestinal Tumors Hindered By Antibody In Lab Tests

An antibody that binds to a molecule on the surface of a rare but deadly tumor of the gastrointestinal tract inhibits the growth of the cancer cells in mice, according to researchers at the Stanford University School of Medicine.

http://www.medilexicon.com/medicalnews.php?newsid=255853